Literature DB >> 396062

Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients.

L Corea, N Miele, M Bentivoglio, E Boschetti, E Agabiti-Rosei, G Muiesan.   

Abstract

1. Nifedipine, a calcium antagonist drug, was given sublingually (10 mg) to seven normal subjects and 19 patients with essential hypertension. In addition, 12 of the hypertensive subjects then received nifedipine (10 mg thrice daily) for 3 weeks. 2. Sublingual administration of nifedipine in hypertensive patients induced a prompt and sustained reduction of blood pressure, without a significant increase of heart rate; in normotensive subjects blood pressure did not change, and heart rate was significantly increased. After chronic treatment, blood pressure remained reduced and heart rate did not rise. 3. Plasma catecholamines and plasma renin activity increased significantly in normotensive subjects after acute administration. 4. After both acute and chronic administration, only plasma noradrenaline was significantly increased in hypertensive patients; in long-term treatment, it was increased in both the lying and standing positions. 5. Nifedipine is an active antihypertensive drug, which may induce some degree of sympathetic activation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 396062     DOI: 10.1042/cs057115s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension.

Authors:  V Mitrovic; W Patyna; J Hüting; M Schlepper
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

3.  Effect of diuretics and calcium antagonists on circulatory parameters and plasma catecholamines during mental stress.

Authors:  E Heidbreder; K Schafferhans; R Kirsten; A Heidland
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Effects of treatment with nifedipine and metoprolol in essential hypertension.

Authors:  R Eggertsen; L Hansson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Nitrendipine and the humoral control of sodium homeostasis.

Authors:  D R Forsyth; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

8.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

10.  Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.

Authors:  J Su; N Renaud; A Carayon; B Crozatier; L Hittinger
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.